This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hori, K. Articles by Zhang, Q.-H. Search for Related Content PubMed PubMed Citation Articles by Hori, K. Articles by Zhang, Q.-H.

Circadian Variation of Tumor Blood Flow in Rat Subcutaneous Tumors and Its Alteration by Angiotensin II-induced Hypertension¹

Department of Experimental Oncology, Research Institute for Tuberculosis and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980, Japan

Circadian fluctuation in tumor blood flow of the rat subcutaneous tumor was investigated. Tumor tissue blood flows in the daytime zone (10 a.m. to 4 p.m.) and in the nighttime zone (10 p.m. to 4 a.m.) in both the first phase (doubling time of tumor volume = 1.7 days) and the second phase (doubling time of tumor volume = 5.7 days) of growth of the LY80 tumor in rats were measured using the hydrogen gas clearance technique. In the first phase of tumor growth, the tumor blood flow was 20.3 ± 12.2 ml/min/100 g in the daytime zone (n = 22) and 46.6 ± 19.3 ml/min/100 g in the nighttime zone (n = 22). In the second phase, tumor blood flow was 9.6 ± 5.7 ml/min/100 g in the daytime zone (n = 45) and 19.4 ± 8.2 ml/min/100 g in the nighttime zone (n = 38). Tumor blood flow in the nighttime zone was significantly higher than that in the daytime zone (first phase, P < 0.001; second phase, P < 0.001). However, there were no significant differences in the mean arterial blood pressure, tumor size, and body weight of rats between the daytime zone and the nighttime zone. There was also a marked difference in the effect of angiotensin II-induced hypertension on tumor blood flow between the daytime zone and the nighttime zone. These results suggest that circadian fluctuations in tumor blood flow should be carefully considered when developing strategies to maximize the effectiveness of cancer therapy in relation to the flow rate of circulating blood.

¹ Supported in part by Grant-in-Aid 01870102 from the Ministry of Education, Science, and Culture of Japan.

² To whom requests for reprints should be addressed.

Received 8/12/91. Accepted 12/ 3/91.

This article has been cited by other articles:

				P. A. Wood, J. Du-Quiton, S. You, and W. J.M. Hrushesky Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol. Cancer Ther., August 1, 2006; 5(8): 2023 - 2033. [Abstract] [Full Text] [PDF]

				W. J. M. Hrushesky The Temporal Organization of Life: the Impact of Multi-frequency Non-linear Biologic Time Structure Upon the Host-Cancer Balance Jpn. J. Clin. Oncol., December 1, 2000; 30(12): 529 - 533. [Abstract] [Full Text] [PDF]